Press release
Lung Cancer and Therapies Meet 2019
Lexis is the world best platform for all the researchers to showcase their on-going research work through Oral/Poster presentations in front of the international audience, provided with additional opportunities for expanding their research work by conducting workshops and by exhibiting products.It gives you the global exposure and helps to associate with the present and potential researchers who discover novel techniques to treat Lung Cancer with different approach. This meet enlightens the latest treatment advancements in Lung Cancer and the researchers around the globe who concentrates on growth about ongoing advances like first stage analysis to treatment etc., this is the best chance to achieve the biggest array of members.
This conference invites Oncologists, Academicians, Physicians, Academic scientists, Radiologists, Chemo therapists, Industry professionals, Head of the departments, Directors, Clinical Professionals, Young researchers, Postgraduates, Trainees and above all Lung cancer Researchers. It also gives the best opportunity to the Business professionals to represent their company.
Lung Cancer Therapies Meet 2019 cordially conducted by the Lexis in Berlin, Germany on May 17-18, 2019 mainly focuses on cause and cure for the Lung Cancer which is the second major cancer causing death to the people around the world. The congress runs with the theme “Interchanging the Scientific Enlightenment about Lung Diseases and Research”.
For more details please follow: https://www.lexisconferences.com/lungcancer
Further queries please feel free to contact us
Thanks & Regards
Sarah Williams
Program Director | Euro Lung Cancer 2019
E: lungcancer@lexisevent.com
4211 Rainier Street, Irving
Texas 75062, USA | T: +1 (214) 972-2216
|||||Lexis
Lexis with the indomitable aim of transforming the fields of Science, Technology and Healthcare, Lexis matches our unshakeable service ethos to the most skilled and enthusiastic professionals. Through our expertise in publishing, event and association management, our goal is to support the scientific communities and networks, as we combine to propel science and health into the future. Lexis believes in integrating innovation with the latest research to remain the preeminent event organizer
4211 Rainier Street, Irving
Texas 75062, USA
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lung Cancer and Therapies Meet 2019 here
News-ID: 1359057 • Views: …
More Releases from Lexis Conferences

Pharma 2020 Webinar: August 17-18, 2020
If we look at the history, innovations don't come just from giving people incentives, it comes from creating an environment where their ideas can connect. Nobody won't get ahead by hiding behind old habits and skills; everyone needs to collaborate with the smartest minds in the field. Scientific congresses are still the best way to do that. Pharma 2020 will have its main focus in discussing the latest high impact…
International Conference on Gastroenterology and Digestive Disorders
It is our extraordinary delight to invite you to the International conference organized by LexisConferences scheduled in Vancouver, Canada during July 27-28, 2020. The conference is organized around the theme "Future Perspectives and shaping trends in Gastroenterology and Digestive Disorders". Gastroenterology and Digestive Disorders 2020 will encourage dialogs and wants to rouse members from a wide cluster of research to start joint efforts inside and over the order of Gastroenterology…
More Releases for Lung
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Lung Cancer Drugs Industry Market Size Be by 2025?
The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate…
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Lending And Payments Market?
The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787
This latest report researches the industry structure,…
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor…